| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROTHBLATT MARTINE A | Chairperson & CEO, Director | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 29 Sep 2025 | 0001106578 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $481,040 | +4,000 | +3077% | $120.26 | 4,130 | 25 Sep 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $386,161 | -900 | -22% | $429.07 | 3,230 | 25 Sep 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $344,202 | -800 | -25% | $430.25 | 2,430 | 25 Sep 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $993,376 | -2,300 | -95% | $431.90 | 130 | 25 Sep 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Options Exercise | $481,040 | +4,000 | +3077% | $120.26 | 4,130 | 26 Sep 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $426,860 | -1,000 | -24% | $426.86 | 3,130 | 26 Sep 2025 | Direct | F1 |
| transaction | UTHR | Common Stock | Sale | $1,286,031 | -3,000 | -96% | $428.68 | 130 | 26 Sep 2025 | Direct | F1, F5 |
| holding | UTHR | Common Stock | 166 | 25 Sep 2025 | by Spouse | ||||||
| holding | UTHR | Common Stock | 324,518 | 25 Sep 2025 | by Trust | F6 | |||||
| holding | UTHR | Common Stock | 258,117 | 25 Sep 2025 | by Trust | F7 | |||||
| holding | UTHR | Common Stock | 45,596 | 25 Sep 2025 | by Trust | F8 | |||||
| holding | UTHR | Common Stock | 15,962 | 25 Sep 2025 | by Trust | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -4,000 | -1.7% | $0.000000 | 238,000 | 25 Sep 2025 | Common Stock | 4,000 | $120.26 | Direct | F1 |
| transaction | UTHR | Stock Option | Options Exercise | $0 | -4,000 | -1.7% | $0.000000 | 234,000 | 26 Sep 2025 | Common Stock | 4,000 | $120.26 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025. |
| F2 | This transaction was executed in multiple trades at prices ranging from $428.79 to $429.415. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $430.16 to $430.42. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $431.56 to $432.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $428.17 to $429.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F7 | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |
| F8 | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. |
| F9 | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. |